ACR

ACR Conference Content

featured article image

ACR 2025: Adipose Tissue-Derived Mesenchymal Stem Cell Therapy vs. Hyaluronic Acid in Refractory KOA

Frieda Wiley

Nov 3, 2025

Read ACR 2025: Secukinumab Found More Effective Than Ustekinumab in First Head-To-Head PsA Trialarticle image

ACR 2025: Secukinumab Found More Effective Than Ustekinumab in First Head-To-Head PsA Trial

Frieda Wiley

Nov 3, 2025 Link to ACR 2025: Secukinumab Found More Effective Than Ustekinumab in First Head-To-Head PsA Trial

Read Looking Ahead to ACR 2025article image

Looking Ahead to ACR 2025

Frieda Wiley

Oct 13, 2025 Link to Looking Ahead to ACR 2025